These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32988429)

  • 1. Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
    López-Abente J; Valor-Suarez C; López-Abente G
    Epidemiol Infect; 2020 Sep; 148():e233. PubMed ID: 32988429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation of the effects of COVID-19 testing rates on hospitalizations.
    Sousa-Pinto B; Fonseca JA; Oliveira B; Cruz-Correia R; Rodrigues PP; Costa-Pereira A; Rocha-Gonçalves FN
    Bull World Health Organ; 2020 May; 98(5):299. PubMed ID: 32514192
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
    Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
    Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of COVID-19 among ophthalmology professionals.
    Lacorzana J; Ortiz-Perez S; Rubio Prats M
    Med Clin (Barc); 2020 Sep; 155(5):225. PubMed ID: 32591177
    [No Abstract]   [Full Text] [Related]  

  • 5. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 6. [COVID-19 and Pulmonology: New Challenges and Opportunities].
    Clérigo V; Duarte P
    Acta Med Port; 2020 Oct; 33(10):710. PubMed ID: 32877327
    [No Abstract]   [Full Text] [Related]  

  • 7. Covid-19: Test and trace programmes are important but no silver bullet, say scientists.
    Griffin S
    BMJ; 2020 May; 369():m2151. PubMed ID: 32467147
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory diagnosis for Covid-19: A mini-review.
    Pizzol JLD; Hora VPD; Reis AJ; Vianna J; Ramis I; Groll AV; Silva PAD
    Rev Soc Bras Med Trop; 2020; 53():e20200451. PubMed ID: 32876316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving reporting criteria of COVID-19 in Taiwan during the epidemic.
    Huang YC; Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):413-418. PubMed ID: 32224117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics].
    Calvo C; Tagarro A; Otheo E; Epalza C; ;
    An Pediatr (Engl Ed); 2020 Apr; 92(4):239-240. PubMed ID: 32241653
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Making the Best Use of Test Kits for COVID-19.
    Weinberg CR
    Am J Epidemiol; 2020 May; 189(5):363-364. PubMed ID: 32378722
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening maternity populations during the COVID-19 pandemic.
    Iida M; Tanaka M
    BJOG; 2020 Nov; 127(12):1557. PubMed ID: 32735760
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological tests for COVID-19.
    Bond K; Williams E; Howden BP; Williamson DA
    Med J Aust; 2020 Nov; 213(9):397-399.e1. PubMed ID: 32892381
    [No Abstract]   [Full Text] [Related]  

  • 14. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.
    Aktaş H; Hamidi AA
    Dermatol Ther; 2020 Jul; 33(4):e13610. PubMed ID: 32418320
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19: An Unintended Force for Medical Revolution?
    Wang X; Bhatt DL
    J Invasive Cardiol; 2020 Apr; 32(4):E81-E82. PubMed ID: 32229647
    [No Abstract]   [Full Text] [Related]  

  • 16. University participation in the production of molecular diagnostic tests for the novel coronavirus in Brazil: the response to health challenges.
    Silva RGLD; Chammas R; Plonski GA; Goldbaum M; Ferreira LCS; Novaes HMD
    Cad Saude Publica; 2020; 36(6):e00115520. PubMed ID: 32609169
    [No Abstract]   [Full Text] [Related]  

  • 17. Simulation of Pool Testing to Identify Patients With Coronavirus Disease 2019 Under Conditions of Limited Test Availability.
    Cherif A; Grobe N; Wang X; Kotanko P
    JAMA Netw Open; 2020 Jun; 3(6):e2013075. PubMed ID: 32573706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer.
    Oladimeji O; Atiba BP; Adeyinka DA
    Pan Afr Med J; 2020; 35(Suppl 2):8. PubMed ID: 32528619
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementing U.S. Covid-19 Testing: Regulatory and Infrastructural Challenges.
    Tan YT; Kesselheim AS
    J Law Med Ethics; 2020 Sep; 48(3):606-612. PubMed ID: 33021179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.